市場調査レポート

商品コード

1120373

世界の泌尿生殖器薬市場：考察と予測 (2028年まで)

Global Genitourinary Drugs Market Insights, Forecast to 2028

出版日: 2022年08月30日 | 発行: QYResearch

| ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、泌尿生殖器薬 (Genitourinary Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

泌尿生殖器薬の製品概要
市場：タイプ別
- 世界の泌尿生殖器薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Urologicals
- Hormonal Therapy
- Gynecological
- Anti-infectives
市場：アプリケーション別
- 世界の泌尿生殖器薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Prostate Cancer
- Ovarian Cancer
- Bladder Cancer
- Cervical Cancer
- Renal Cancer
- Erectile Dysfunction
- Urinary Tract Infections
- Urinary Incontinence & Overactive Bladder
- Sexually Transmitted Diseases
調査目的
対象期間

第2章レポート概要

世界の泌尿生殖器薬の販売推定および予測 2017-2028
世界の泌尿生殖器薬の収益推定および予測 2017-2028
世界の泌尿生殖器薬の収益：地域別: 2017 VS 2021 VS 2028
世界の泌尿生殖器薬の販売：地域別
- 世界の泌尿生殖器薬の販売：地域別 (2017-2022)
- 世界の販売泌尿生殖器薬：地域別 (2023-2028)
世界の泌尿生殖器薬の収益：地域別
- 世界の泌尿生殖器薬の収益：地域別 (2017-2022)
- 世界の泌尿生殖器薬の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の泌尿生殖器薬の販売：メーカー別
- 世界の泌尿生殖器薬の上位メーカー：販売別 (2017-2022)
- 世界の泌尿生殖器薬の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：泌尿生殖器薬2021
世界の泌尿生殖器薬の収益：メーカー別
- 世界の泌尿生殖器薬の収益：メーカー別 (2017-2022)
- 世界の泌尿生殖器薬の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：泌尿生殖器薬の収益 2021
世界の泌尿生殖器薬の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の泌尿生殖器薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の泌尿生殖器薬のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の泌尿生殖器薬の販売：タイプ別
- 世界の泌尿生殖器薬の販売実績：タイプ別 (2017-2022)
- 世界の泌尿生殖器薬の販売予測：タイプ別 (2023-2028)
- 世界の泌尿生殖器薬の販売市場シェア：タイプ別 (2017-2028)
世界の泌尿生殖器薬の収益：タイプ別
- 世界の泌尿生殖器薬の収益実績：タイプ別 (2017-2022)
- 世界の泌尿生殖器薬の収益予測：タイプ別 (2023-2028)
- 世界の泌尿生殖器薬の収益市場シェア：タイプ別 (2017-2028)
世界の泌尿生殖器薬の価格：タイプ別
- 世界の泌尿生殖器薬の価格：タイプ別 (2017-2022)
- 世界の泌尿生殖器薬の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の泌尿生殖器薬の販売：アプリケーション別
- 世界の泌尿生殖器薬の販売実績：アプリケーション別 (2017-2022)
- 世界の泌尿生殖器薬の販売予測：アプリケーション別 (2023-2028)
- 世界の泌尿生殖器薬の販売市場シェア：アプリケーション別 (2017-2028)
世界の泌尿生殖器薬の収益：アプリケーション別
- 世界の泌尿生殖器薬の収益実績：アプリケーション別 (2017-2022)
- 世界の泌尿生殖器薬の収益予測：アプリケーション別 (2023-2028)
- 世界の泌尿生殖器薬の収益市場シェア：アプリケーション別 (2017-2028)
世界の泌尿生殖器薬の価格：アプリケーション別
- 世界の泌尿生殖器薬の価格：アプリケーション別 (2017-2022)
- 世界の泌尿生殖器薬の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の泌尿生殖器薬市場規模：タイプ別
- 北米の泌尿生殖器薬の販売：タイプ別 (2017-2028)
- 北米の泌尿生殖器薬の収益：タイプ別 (2017-2028)
北米の泌尿生殖器薬市場規模：アプリケーション別
- 北米の泌尿生殖器薬の販売：アプリケーション別 (2017-2028)
- 北米の泌尿生殖器薬の収益：アプリケーション別 (2017-2028)
北米の泌尿生殖器薬市場規模：国別
- 北米の泌尿生殖器薬の販売：国別 (2017-2028)
- 北米の泌尿生殖器薬の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の泌尿生殖器薬市場規模：タイプ別
- 欧州の泌尿生殖器薬の販売：タイプ別 (2017-2028)
- 欧州の泌尿生殖器薬の収益：タイプ別 (2017-2028)
欧州の泌尿生殖器薬市場規模：アプリケーション別
- 欧州の泌尿生殖器薬の販売：アプリケーション別 (2017-2028)
- 欧州の泌尿生殖器薬の収益：アプリケーション別 (2017-2028)
欧州の泌尿生殖器薬市場規模：国別
- 欧州の泌尿生殖器薬の販売：国別 (2017-2028)
- 欧州の泌尿生殖器薬の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の泌尿生殖器薬市場規模：タイプ別
- アジア太平洋の泌尿生殖器薬の販売：タイプ別 (2017-2028)
- アジア太平洋の泌尿生殖器薬の収益：タイプ別 (2017-2028)
アジア太平洋の泌尿生殖器薬市場規模：アプリケーション別
- アジア太平洋の泌尿生殖器薬の販売：アプリケーション別 (2017-2028)
- アジア太平洋の泌尿生殖器薬の収益：アプリケーション別 (2017-2028)
アジア太平洋の泌尿生殖器薬市場規模：地域別
- アジア太平洋の泌尿生殖器薬の販売：地域別 (2017-2028)
- アジア太平洋の泌尿生殖器薬の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの泌尿生殖器薬市場規模：タイプ別
- ラテンアメリカの泌尿生殖器薬の販売：タイプ別 (2017-2028)
- ラテンアメリカの泌尿生殖器薬の収益：タイプ別 (2017-2028)
ラテンアメリカの泌尿生殖器薬市場規模：アプリケーション別
- ラテンアメリカの泌尿生殖器薬の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの泌尿生殖器薬の収益：アプリケーション別 (2017-2028)
ラテンアメリカの泌尿生殖器薬市場規模：国別
- ラテンアメリカの泌尿生殖器薬の販売：国別 (2017-2028)
- ラテンアメリカの泌尿生殖器薬の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの泌尿生殖器薬市場規模：タイプ別
- 中東・アフリカの泌尿生殖器薬の販売：タイプ別 (2017-2028)
- 中東・アフリカの泌尿生殖器薬の収益：タイプ別 (2017-2028)
中東・アフリカの泌尿生殖器薬市場規模：アプリケーション別
- 中東・アフリカの泌尿生殖器薬の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの泌尿生殖器薬の収益：アプリケーション別 (2017-2028)
中東・アフリカの泌尿生殖器薬市場規模：国別
- 中東・アフリカの泌尿生殖器薬の販売：国別 (2017-2028)
- 中東・アフリカの泌尿生殖器薬の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

Novartis AG
Genentech

第12章業界チェーンと販売チャネルの分析

泌尿生殖器薬業界チェーン分析
泌尿生殖器薬主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
泌尿生殖器薬生産形態とプロセス
泌尿生殖器薬販売およびマーケティング
- 泌尿生殖器薬販売チャネル
- 泌尿生殖器薬卸業者
泌尿生殖器薬顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

泌尿生殖器薬業界動向
泌尿生殖器薬市場の促進要因
泌尿生殖器薬市場の課題
泌尿生殖器薬市場の抑制要因

第14章世界の泌尿生殖器薬の主な市場調査結果

第15章付録

図表

Table 1. Global Genitourinary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Urologicals
Table 3. Major Manufacturers of Hormonal Therapy
Table 4. Major Manufacturers of Gynecological
Table 5. Major Manufacturers of Anti-infectives
Table 6. Global Genitourinary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Genitourinary Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Genitourinary Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Genitourinary Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global Genitourinary Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Genitourinary Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Genitourinary Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Genitourinary Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Genitourinary Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Genitourinary Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Genitourinary Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Genitourinary Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Genitourinary Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Genitourinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Genitourinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genitourinary Drugs as of 2021)
Table 23. Genitourinary Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Genitourinary Drugs Product Offered
Table 25. Date of Manufacturers Enter into Genitourinary Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global Genitourinary Drugs Sales Share by Type (2017-2022)
Table 30. Global Genitourinary Drugs Sales Share by Type (2023-2028)
Table 31. Global Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Genitourinary Drugs Revenue Share by Type (2017-2022)
Table 34. Global Genitourinary Drugs Revenue Share by Type (2023-2028)
Table 35. Genitourinary Drugs Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Genitourinary Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global Genitourinary Drugs Sales Share by Application (2017-2022)
Table 40. Global Genitourinary Drugs Sales Share by Application (2023-2028)
Table 41. Global Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Genitourinary Drugs Revenue Share by Application (2017-2022)
Table 44. Global Genitourinary Drugs Revenue Share by Application (2023-2028)
Table 45. Genitourinary Drugs Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Genitourinary Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America Genitourinary Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe Genitourinary Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Genitourinary Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Genitourinary Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Genitourinary Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Genitourinary Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Genitourinary Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Genitourinary Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Genitourinary Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Genitourinary Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novartis AG Corporation Information
Table 108. Novartis AG Description and Major Businesses
Table 109. Novartis AG Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Novartis AG Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis AG Recent Developments
Table 112. Genentech Corporation Information
Table 113. Genentech Description and Major Businesses
Table 114. Genentech Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Genentech Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Genentech Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Genitourinary Drugs Distributors List
Table 120. Genitourinary Drugs Customers List
Table 121. Genitourinary Drugs Market Trends
Table 122. Genitourinary Drugs Market Drivers
Table 123. Genitourinary Drugs Market Challenges
Table 124. Genitourinary Drugs Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Genitourinary Drugs Product Picture
Figure 3. Global Genitourinary Drugs Market Share by Type in 2021 & 2028
Figure 3. Urologicals Product Picture
Figure 4. Hormonal Therapy Product Picture
Figure 5. Gynecological Product Picture
Figure 6. Anti-infectives Product Picture
Figure 7. Global Genitourinary Drugs Market Share by Application in 2021 & 2028
Figure 8. Prostate Cancer
Figure 9. Ovarian Cancer
Figure 10. Bladder Cancer
Figure 11. Cervical Cancer
Figure 12. Renal Cancer
Figure 13. Erectile Dysfunction
Figure 14. Urinary Tract Infections
Figure 15. Urinary Incontinence & Overactive Bladder
Figure 16. Sexually Transmitted Diseases
Figure 17. Genitourinary Drugs Report Years Considered
Figure 18. Global Genitourinary Drugs Sales 2017-2028 (K Units)
Figure 19. Global Genitourinary Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Genitourinary Drugs Revenue 2017-2028 (US$ Million)
Figure 21. Global Genitourinary Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)
Figure 23. Global Genitourinary Drugs Sales Market Share by Region (2023-2028)
Figure 24. North America Genitourinary Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. North America Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Genitourinary Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Europe Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Genitourinary Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Asia-Pacific Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Genitourinary Drugs Sales YoY (2017-2028) & (K Units)
Figure 31. Latin America Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Genitourinary Drugs Sales YoY (2017-2028) & (K Units)
Figure 33. Middle East & Africa Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Genitourinary Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Genitourinary Drugs in the World: Market Share by Genitourinary Drugs Revenue in 2021
Figure 36. Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 41. North America Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 42. North America Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 43. North America Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 45. North America Genitourinary Drugs Sales Share by Country (2017-2028)
Figure 46. North America Genitourinary Drugs Revenue Share by Country (2017-2028)
Figure 47. U.S. Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 51. Europe Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 53. Europe Genitourinary Drugs Sales Share by Country (2017-2028)
Figure 54. Europe Genitourinary Drugs Revenue Share by Country (2017-2028)
Figure 55. Germany Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. France Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Genitourinary Drugs Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Genitourinary Drugs Revenue Share by Region (2017-2028)
Figure 66. China Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. India Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Taiwan Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Philippines Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 77. Latin America Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 79. Latin America Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Genitourinary Drugs Sales Share by Country (2017-2028)
Figure 81. Latin America Genitourinary Drugs Revenue Share by Country (2017-2028)
Figure 82. Mexico Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Genitourinary Drugs Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Genitourinary Drugs Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Genitourinary Drugs Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Genitourinary Drugs Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Genitourinary Drugs Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Genitourinary Drugs Revenue Share by Country (2017-2028)
Figure 91. Turkey Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Genitourinary Drugs Revenue (2017-2028) & (US$ Million)
Figure 94. Genitourinary Drugs Value Chain
Figure 95. Genitourinary Drugs Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

This research report focuses on the Genitourinary Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Genitourinary Drugs Product Introduction
1.2 Market by Type
- 1.2.1 Global Genitourinary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Urologicals
- 1.2.3 Hormonal Therapy
- 1.2.4 Gynecological
- 1.2.5 Anti-infectives
1.3 Market by Application
- 1.3.1 Global Genitourinary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Prostate Cancer
- 1.3.3 Ovarian Cancer
- 1.3.4 Bladder Cancer
- 1.3.5 Cervical Cancer
- 1.3.6 Renal Cancer
- 1.3.7 Erectile Dysfunction
- 1.3.8 Urinary Tract Infections
- 1.3.9 Urinary Incontinence & Overactive Bladder
- 1.3.10 Sexually Transmitted Diseases
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Genitourinary Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Genitourinary Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Genitourinary Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Genitourinary Drugs Sales by Region
- 2.4.1 Global Genitourinary Drugs Sales by Region (2017-2022)
- 2.4.2 Global Sales Genitourinary Drugs by Region (2023-2028)
2.5 Global Genitourinary Drugs Revenue by Region
- 2.5.1 Global Genitourinary Drugs Revenue by Region (2017-2022)
- 2.5.2 Global Genitourinary Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Genitourinary Drugs Sales by Manufacturers
- 3.1.1 Global Top Genitourinary Drugs Manufacturers by Sales (2017-2022)
- 3.1.2 Global Genitourinary Drugs Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genitourinary Drugs in 2021
3.2 Global Genitourinary Drugs Revenue by Manufacturers
- 3.2.1 Global Genitourinary Drugs Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Genitourinary Drugs Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2021
3.3 Global Genitourinary Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Genitourinary Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Genitourinary Drugs Sales by Type
- 4.1.1 Global Genitourinary Drugs Historical Sales by Type (2017-2022)
- 4.1.2 Global Genitourinary Drugs Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Genitourinary Drugs Sales Market Share by Type (2017-2028)
4.2 Global Genitourinary Drugs Revenue by Type
- 4.2.1 Global Genitourinary Drugs Historical Revenue by Type (2017-2022)
- 4.2.2 Global Genitourinary Drugs Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Genitourinary Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Genitourinary Drugs Price by Type
- 4.3.1 Global Genitourinary Drugs Price by Type (2017-2022)
- 4.3.2 Global Genitourinary Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Genitourinary Drugs Sales by Application
- 5.1.1 Global Genitourinary Drugs Historical Sales by Application (2017-2022)
- 5.1.2 Global Genitourinary Drugs Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Genitourinary Drugs Sales Market Share by Application (2017-2028)
5.2 Global Genitourinary Drugs Revenue by Application
- 5.2.1 Global Genitourinary Drugs Historical Revenue by Application (2017-2022)
- 5.2.2 Global Genitourinary Drugs Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Genitourinary Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Genitourinary Drugs Price by Application
- 5.3.1 Global Genitourinary Drugs Price by Application (2017-2022)
- 5.3.2 Global Genitourinary Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Genitourinary Drugs Market Size by Type
- 6.1.1 North America Genitourinary Drugs Sales by Type (2017-2028)
- 6.1.2 North America Genitourinary Drugs Revenue by Type (2017-2028)
6.2 North America Genitourinary Drugs Market Size by Application
- 6.2.1 North America Genitourinary Drugs Sales by Application (2017-2028)
- 6.2.2 North America Genitourinary Drugs Revenue by Application (2017-2028)
6.3 North America Genitourinary Drugs Market Size by Country
- 6.3.1 North America Genitourinary Drugs Sales by Country (2017-2028)
- 6.3.2 North America Genitourinary Drugs Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Genitourinary Drugs Market Size by Type
- 7.1.1 Europe Genitourinary Drugs Sales by Type (2017-2028)
- 7.1.2 Europe Genitourinary Drugs Revenue by Type (2017-2028)
7.2 Europe Genitourinary Drugs Market Size by Application
- 7.2.1 Europe Genitourinary Drugs Sales by Application (2017-2028)
- 7.2.2 Europe Genitourinary Drugs Revenue by Application (2017-2028)
7.3 Europe Genitourinary Drugs Market Size by Country
- 7.3.1 Europe Genitourinary Drugs Sales by Country (2017-2028)
- 7.3.2 Europe Genitourinary Drugs Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Genitourinary Drugs Market Size by Type
- 8.1.1 Asia Pacific Genitourinary Drugs Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Genitourinary Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Genitourinary Drugs Market Size by Application
- 8.2.1 Asia Pacific Genitourinary Drugs Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Genitourinary Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Genitourinary Drugs Market Size by Region
- 8.3.1 Asia Pacific Genitourinary Drugs Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Genitourinary Drugs Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Genitourinary Drugs Market Size by Type
- 9.1.1 Latin America Genitourinary Drugs Sales by Type (2017-2028)
- 9.1.2 Latin America Genitourinary Drugs Revenue by Type (2017-2028)
9.2 Latin America Genitourinary Drugs Market Size by Application
- 9.2.1 Latin America Genitourinary Drugs Sales by Application (2017-2028)
- 9.2.2 Latin America Genitourinary Drugs Revenue by Application (2017-2028)
9.3 Latin America Genitourinary Drugs Market Size by Country
- 9.3.1 Latin America Genitourinary Drugs Sales by Country (2017-2028)
- 9.3.2 Latin America Genitourinary Drugs Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Genitourinary Drugs Market Size by Type
- 10.1.1 Middle East and Africa Genitourinary Drugs Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Genitourinary Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Genitourinary Drugs Market Size by Application
- 10.2.1 Middle East and Africa Genitourinary Drugs Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Genitourinary Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Genitourinary Drugs Market Size by Country
- 10.3.1 Middle East and Africa Genitourinary Drugs Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 Novartis AG
- 11.1.1 Novartis AG Corporation Information
- 11.1.2 Novartis AG Overview
- 11.1.3 Novartis AG Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Novartis AG Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Novartis AG Recent Developments
11.2 Genentech
- 11.2.1 Genentech Corporation Information
- 11.2.2 Genentech Overview
- 11.2.3 Genentech Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Genentech Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Genentech Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Genitourinary Drugs Industry Chain Analysis
12.2 Genitourinary Drugs Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Genitourinary Drugs Production Mode & Process
12.4 Genitourinary Drugs Sales and Marketing
- 12.4.1 Genitourinary Drugs Sales Channels
- 12.4.2 Genitourinary Drugs Distributors
12.5 Genitourinary Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Genitourinary Drugs Industry Trends
13.2 Genitourinary Drugs Market Drivers
13.3 Genitourinary Drugs Market Challenges
13.4 Genitourinary Drugs Market Restraints

14 Key Findings in The Global Genitourinary Drugs Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

世界の泌尿生殖器薬市場：考察と予測 (2028年まで)

Global Genitourinary Drugs Market Insights, Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の泌尿生殖器薬の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Genitourinary Drugs Study

15 Appendix

世界の泌尿生殖器薬市場：考察と予測 (2028年まで)

Global Genitourinary Drugs Market Insights, Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の泌尿生殖器薬の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Genitourinary Drugs Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の泌尿生殖器薬の主な市場調査結果

第15章付録